Close Menu

Two years after completing proof-of-concept experiments for its IDBEST technology, Target Discovery has formed collaborations with the MD Anderson Cancer Center and the Eastern Virginia Medical School to develop protein isoform-based diagnostics for breast, prostate and ovarian cancer.

The Palo Alto, Calif.-based company is currently picking a list of biomarkers that will be examined for isoform differences. Researchers will then whittle down the markers to two or three promising isoforms on which to perform a larger validation study.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.